Summary
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.
According to APO Research, The global Tuberculosis Vaccine Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Tuberculosis Vaccine Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Tuberculosis Vaccine Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Tuberculosis Vaccine Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Tuberculosis Vaccine Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Tuberculosis Vaccine Treatment include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin and Taj Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Tuberculosis Vaccine Treatment, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Tuberculosis Vaccine Treatment, also provides the sales of main regions and countries. Of the upcoming market potential for Tuberculosis Vaccine Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Tuberculosis Vaccine Treatment sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Tuberculosis Vaccine Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Tuberculosis Vaccine Treatment sales, projected growth trends, production technology, application and end-user industry.
Tuberculosis Vaccine Treatment segment by Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Tuberculosis Vaccine Treatment segment by Type
Immune Vaccine
Therapy Vaccine
Tuberculosis Vaccine Treatment segment by Application
Self-Procurement
UNICEF
Other
Tuberculosis Vaccine Treatment segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis Vaccine Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis Vaccine Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis Vaccine Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Tuberculosis Vaccine Treatment in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Tuberculosis Vaccine Treatment manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tuberculosis Vaccine Treatment sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Tuberculosis Vaccine Treatment Market by Type
1.2.1 Global Tuberculosis Vaccine Treatment Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 Tuberculosis Vaccine Treatment Market by Application
1.3.1 Global Tuberculosis Vaccine Treatment Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Tuberculosis Vaccine Treatment Market Dynamics
2.1 Tuberculosis Vaccine Treatment Industry Trends
2.2 Tuberculosis Vaccine Treatment Industry Drivers
2.3 Tuberculosis Vaccine Treatment Industry Opportunities and Challenges
2.4 Tuberculosis Vaccine Treatment Industry Restraints
3 Global Market Growth Prospects
3.1 Global Tuberculosis Vaccine Treatment Revenue Estimates and Forecasts (2019-2030)
3.2 Global Tuberculosis Vaccine Treatment Revenue by Region
3.2.1 Global Tuberculosis Vaccine Treatment Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Tuberculosis Vaccine Treatment Revenue by Region (2019-2024)
3.2.3 Global Tuberculosis Vaccine Treatment Revenue by Region (2025-2030)
3.2.4 Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2019-2030)
3.3 Global Tuberculosis Vaccine Treatment Sales Estimates and Forecasts 2019-2030
3.4 Global Tuberculosis Vaccine Treatment Sales by Region
3.4.1 Global Tuberculosis Vaccine Treatment Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Tuberculosis Vaccine Treatment Sales by Region (2019-2024)
3.4.3 Global Tuberculosis Vaccine Treatment Sales by Region (2025-2030)
3.4.4 Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Tuberculosis Vaccine Treatment Revenue by Manufacturers
4.1.1 Global Tuberculosis Vaccine Treatment Revenue by Manufacturers (2019-2024)
4.1.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Tuberculosis Vaccine Treatment Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Tuberculosis Vaccine Treatment Sales by Manufacturers
4.2.1 Global Tuberculosis Vaccine Treatment Sales by Manufacturers (2019-2024)
4.2.2 Global Tuberculosis Vaccine Treatment Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Tuberculosis Vaccine Treatment Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Tuberculosis Vaccine Treatment Sales Price by Manufacturers (2019-2024)
4.4 Global Tuberculosis Vaccine Treatment Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Tuberculosis Vaccine Treatment Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Tuberculosis Vaccine Treatment Manufacturers, Product Type & Application
4.7 Global Tuberculosis Vaccine Treatment Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Tuberculosis Vaccine Treatment Market CR5 and HHI
4.8.2 2023 Tuberculosis Vaccine Treatment Tier 1, Tier 2, and Tier 3
5 Tuberculosis Vaccine Treatment Market by Type
5.1 Global Tuberculosis Vaccine Treatment Revenue by Type
5.1.1 Global Tuberculosis Vaccine Treatment Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Tuberculosis Vaccine Treatment Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2019-2030)
5.2 Global Tuberculosis Vaccine Treatment Sales by Type
5.2.1 Global Tuberculosis Vaccine Treatment Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Tuberculosis Vaccine Treatment Sales by Type (2019-2030) & (K Dose)
5.2.3 Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2019-2030)
5.3 Global Tuberculosis Vaccine Treatment Price by Type
6 Tuberculosis Vaccine Treatment Market by Application
6.1 Global Tuberculosis Vaccine Treatment Revenue by Application
6.1.1 Global Tuberculosis Vaccine Treatment Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Tuberculosis Vaccine Treatment Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2019-2030)
6.2 Global Tuberculosis Vaccine Treatment Sales by Application
6.2.1 Global Tuberculosis Vaccine Treatment Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Tuberculosis Vaccine Treatment Sales by Application (2019-2030) & (K Dose)
6.2.3 Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2019-2030)
6.3 Global Tuberculosis Vaccine Treatment Price by Application
7 Company Profiles
7.1 Merck
7.1.1 Merck Comapny Information
7.1.2 Merck Business Overview
7.1.3 Merck Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Merck Tuberculosis Vaccine Treatment Product Portfolio
7.1.5 Merck Recent Developments
7.2 Japan BCG Lab
7.2.1 Japan BCG Lab Comapny Information
7.2.2 Japan BCG Lab Business Overview
7.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Japan BCG Lab Tuberculosis Vaccine Treatment Product Portfolio
7.2.5 Japan BCG Lab Recent Developments
7.3 Serum Institute of India
7.3.1 Serum Institute of India Comapny Information
7.3.2 Serum Institute of India Business Overview
7.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Serum Institute of India Tuberculosis Vaccine Treatment Product Portfolio
7.3.5 Serum Institute of India Recent Developments
7.4 AJ Vaccines
7.4.1 AJ Vaccines Comapny Information
7.4.2 AJ Vaccines Business Overview
7.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 AJ Vaccines Tuberculosis Vaccine Treatment Product Portfolio
7.4.5 AJ Vaccines Recent Developments
7.5 BioFarma
7.5.1 BioFarma Comapny Information
7.5.2 BioFarma Business Overview
7.5.3 BioFarma Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 BioFarma Tuberculosis Vaccine Treatment Product Portfolio
7.5.5 BioFarma Recent Developments
7.6 GreenSignal Bio Pharma
7.6.1 GreenSignal Bio Pharma Comapny Information
7.6.2 GreenSignal Bio Pharma Business Overview
7.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Portfolio
7.6.5 GreenSignal Bio Pharma Recent Developments
7.7 China National Biotec
7.7.1 China National Biotec Comapny Information
7.7.2 China National Biotec Business Overview
7.7.3 China National Biotec Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 China National Biotec Tuberculosis Vaccine Treatment Product Portfolio
7.7.5 China National Biotec Recent Developments
7.8 Biomed Lublin
7.8.1 Biomed Lublin Comapny Information
7.8.2 Biomed Lublin Business Overview
7.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Biomed Lublin Tuberculosis Vaccine Treatment Product Portfolio
7.8.5 Biomed Lublin Recent Developments
7.9 Taj Pharmaceuticals
7.9.1 Taj Pharmaceuticals Comapny Information
7.9.2 Taj Pharmaceuticals Business Overview
7.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Portfolio
7.9.5 Taj Pharmaceuticals Recent Developments
7.10 Ataulpho de Paiva
7.10.1 Ataulpho de Paiva Comapny Information
7.10.2 Ataulpho de Paiva Business Overview
7.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Portfolio
7.10.5 Ataulpho de Paiva Recent Developments
7.11 IVAC
7.11.1 IVAC Comapny Information
7.11.2 IVAC Business Overview
7.11.3 IVAC Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 IVAC Tuberculosis Vaccine Treatment Product Portfolio
7.11.5 IVAC Recent Developments
7.12 Queen Saovabha Mem. Inst
7.12.1 Queen Saovabha Mem. Inst Comapny Information
7.12.2 Queen Saovabha Mem. Inst Business Overview
7.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Portfolio
7.12.5 Queen Saovabha Mem. Inst Recent Developments
7.13 Microgen
7.13.1 Microgen Comapny Information
7.13.2 Microgen Business Overview
7.13.3 Microgen Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 Microgen Tuberculosis Vaccine Treatment Product Portfolio
7.13.5 Microgen Recent Developments
8 North America
8.1 North America Tuberculosis Vaccine Treatment Market Size by Type
8.1.1 North America Tuberculosis Vaccine Treatment Revenue by Type (2019-2030)
8.1.2 North America Tuberculosis Vaccine Treatment Sales by Type (2019-2030)
8.1.3 North America Tuberculosis Vaccine Treatment Price by Type (2019-2030)
8.2 North America Tuberculosis Vaccine Treatment Market Size by Application
8.2.1 North America Tuberculosis Vaccine Treatment Revenue by Application (2019-2030)
8.2.2 North America Tuberculosis Vaccine Treatment Sales by Application (2019-2030)
8.2.3 North America Tuberculosis Vaccine Treatment Price by Application (2019-2030)
8.3 North America Tuberculosis Vaccine Treatment Market Size by Country
8.3.1 North America Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Tuberculosis Vaccine Treatment Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Tuberculosis Vaccine Treatment Price by Country (2019-2030)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Tuberculosis Vaccine Treatment Market Size by Type
9.1.1 Europe Tuberculosis Vaccine Treatment Revenue by Type (2019-2030)
9.1.2 Europe Tuberculosis Vaccine Treatment Sales by Type (2019-2030)
9.1.3 Europe Tuberculosis Vaccine Treatment Price by Type (2019-2030)
9.2 Europe Tuberculosis Vaccine Treatment Market Size by Application
9.2.1 Europe Tuberculosis Vaccine Treatment Revenue by Application (2019-2030)
9.2.2 Europe Tuberculosis Vaccine Treatment Sales by Application (2019-2030)
9.2.3 Europe Tuberculosis Vaccine Treatment Price by Application (2019-2030)
9.3 Europe Tuberculosis Vaccine Treatment Market Size by Country
9.3.1 Europe Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Tuberculosis Vaccine Treatment Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Tuberculosis Vaccine Treatment Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Tuberculosis Vaccine Treatment Market Size by Type
10.1.1 China Tuberculosis Vaccine Treatment Revenue by Type (2019-2030)
10.1.2 China Tuberculosis Vaccine Treatment Sales by Type (2019-2030)
10.1.3 China Tuberculosis Vaccine Treatment Price by Type (2019-2030)
10.2 China Tuberculosis Vaccine Treatment Market Size by Application
10.2.1 China Tuberculosis Vaccine Treatment Revenue by Application (2019-2030)
10.2.2 China Tuberculosis Vaccine Treatment Sales by Application (2019-2030)
10.2.3 China Tuberculosis Vaccine Treatment Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Tuberculosis Vaccine Treatment Market Size by Type
11.1.1 Asia Tuberculosis Vaccine Treatment Revenue by Type (2019-2030)
11.1.2 Asia Tuberculosis Vaccine Treatment Sales by Type (2019-2030)
11.1.3 Asia Tuberculosis Vaccine Treatment Price by Type (2019-2030)
11.2 Asia Tuberculosis Vaccine Treatment Market Size by Application
11.2.1 Asia Tuberculosis Vaccine Treatment Revenue by Application (2019-2030)
11.2.2 Asia Tuberculosis Vaccine Treatment Sales by Application (2019-2030)
11.2.3 Asia Tuberculosis Vaccine Treatment Price by Application (2019-2030)
11.3 Asia Tuberculosis Vaccine Treatment Market Size by Country
11.3.1 Asia Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Tuberculosis Vaccine Treatment Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Tuberculosis Vaccine Treatment Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Tuberculosis Vaccine Treatment Market Size by Type
12.1.1 MEALA Tuberculosis Vaccine Treatment Revenue by Type (2019-2030)
12.1.2 MEALA Tuberculosis Vaccine Treatment Sales by Type (2019-2030)
12.1.3 MEALA Tuberculosis Vaccine Treatment Price by Type (2019-2030)
12.2 MEALA Tuberculosis Vaccine Treatment Market Size by Application
12.2.1 MEALA Tuberculosis Vaccine Treatment Revenue by Application (2019-2030)
12.2.2 MEALA Tuberculosis Vaccine Treatment Sales by Application (2019-2030)
12.2.3 MEALA Tuberculosis Vaccine Treatment Price by Application (2019-2030)
12.3 MEALA Tuberculosis Vaccine Treatment Market Size by Country
12.3.1 MEALA Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Tuberculosis Vaccine Treatment Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Tuberculosis Vaccine Treatment Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Tuberculosis Vaccine Treatment Value Chain Analysis
13.1.1 Tuberculosis Vaccine Treatment Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Tuberculosis Vaccine Treatment Production Mode & Process
13.2 Tuberculosis Vaccine Treatment Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Tuberculosis Vaccine Treatment Distributors
13.2.3 Tuberculosis Vaccine Treatment Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
List of Tables
Table 1. Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Immune Vaccine Major Manufacturers
Table 3. Therapy Vaccine Major Manufacturers
Table 4. Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Self-Procurement Major Manufacturers
Table 6. UNICEF Major Manufacturers
Table 7. Other Major Manufacturers
Table 8. Tuberculosis Vaccine Treatment Industry Trends
Table 9. Tuberculosis Vaccine Treatment Industry Drivers
Table 10. Tuberculosis Vaccine Treatment Industry Opportunities and Challenges
Table 11. Tuberculosis Vaccine Treatment Industry Restraints
Table 12. Global Tuberculosis Vaccine Treatment Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 13. Global Tuberculosis Vaccine Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 14. Global Tuberculosis Vaccine Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 15. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2019-2024)
Table 16. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2025-2030)
Table 17. Global Tuberculosis Vaccine Treatment Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Dose)
Table 18. Global Tuberculosis Vaccine Treatment Sales by Region (2019-2024) & (K Dose)
Table 19. Global Tuberculosis Vaccine Treatment Sales by Region (2025-2030) & (K Dose)
Table 20. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2019-2024)
Table 21. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2025-2030)
Table 22. Global Tuberculosis Vaccine Treatment Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 23. Global Tuberculosis Vaccine Treatment Revenue Market Share by Manufacturers (2019-2024)
Table 24. Global Tuberculosis Vaccine Treatment Sales by Manufacturers (US$ Million) & (2019-2024)
Table 25. Global Tuberculosis Vaccine Treatment Sales Market Share by Manufacturers (2019-2024)
Table 26. Global Tuberculosis Vaccine Treatment Sales Price (USD/K Dose) of Manufacturers (2019-2024)
Table 27. Global Tuberculosis Vaccine Treatment Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 28. Global Tuberculosis Vaccine Treatment Key Manufacturers Manufacturing Sites & Headquarters
Table 29. Global Tuberculosis Vaccine Treatment Manufacturers, Product Type & Application
Table 30. Global Tuberculosis Vaccine Treatment Manufacturers Commercialization Time
Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Tuberculosis Vaccine Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 33. Global Tuberculosis Vaccine Treatment Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 34. Global Tuberculosis Vaccine Treatment Revenue by Type (2019-2024) & (US$ Million)
Table 35. Global Tuberculosis Vaccine Treatment Revenue by Type (2025-2030) & (US$ Million)
Table 36. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2019-2024)
Table 37. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2025-2030)
Table 38. Global Tuberculosis Vaccine Treatment Sales by Type 2019 VS 2023 VS 2030 (K Dose)
Table 39. Global Tuberculosis Vaccine Treatment Sales by Type (2019-2024) & (K Dose)
Table 40. Global Tuberculosis Vaccine Treatment Sales by Type (2025-2030) & (K Dose)
Table 41. Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2019-2024)
Table 42. Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2025-2030)
Table 43. Global Tuberculosis Vaccine Treatment Price by Type (2019-2024) & (USD/K Dose)
Table 44. Global Tuberculosis Vaccine Treatment Price by Type (2025-2030) & (USD/K Dose)
Table 45. Global Tuberculosis Vaccine Treatment Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Global Tuberculosis Vaccine Treatment Revenue by Application (2019-2024) & (US$ Million)
Table 47. Global Tuberculosis Vaccine Treatment Revenue by Application (2025-2030) & (US$ Million)
Table 48. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2019-2024)
Table 49. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2025-2030)
Table 50. Global Tuberculosis Vaccine Treatment Sales by Application 2019 VS 2023 VS 2030 (K Dose)
Table 51. Global Tuberculosis Vaccine Treatment Sales by Application (2019-2024) & (K Dose)
Table 52. Global Tuberculosis Vaccine Treatment Sales by Application (2025-2030) & (K Dose)
Table 53. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2019-2024)
Table 54. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2025-2030)
Table 55. Global Tuberculosis Vaccine Treatment Price by Application (2019-2024) & (USD/K Dose)
Table 56. Global Tuberculosis Vaccine Treatment Price by Application (2025-2030) & (USD/K Dose)
Table 57. Merck Company Information
Table 58. Merck Business Overview
Table 59. Merck Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2019-2024)
Table 60. Merck Tuberculosis Vaccine Treatment Product Portfolio
Table 61. Merck Recent Development
Table 62. Japan BCG Lab Company Information
Table 63. Japan BCG Lab Business Overview
Table 64. Japan BCG Lab Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2019-2024)
Table 65. Japan BCG Lab Tuberculosis Vaccine Treatment Product Portfolio
Table 66. Japan BCG Lab Recent Development
Table 67. Serum Institute of India Company Information
Table 68. Serum Institute of India Business Overview
Table 69. Serum Institute of India Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2019-2024)
Table 70. Serum Institute of India Tuberculosis Vaccine Treatment Product Portfolio
Table 71. Serum Institute of India Recent Development
Table 72. AJ Vaccines Company Information
Table 73. AJ Vaccines Business Overview
Table 74. AJ Vaccines Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2019-2024)
Table 75. AJ Vaccines Tuberculosis Vaccine Treatment Product Portfolio
Table 76. AJ Vaccines Recent Development
Table 77. BioFarma Company Information
Table 78. BioFarma Business Overview
Table 79. BioFarma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2019-2024)
Table 80. BioFarma Tuberculosis Vaccine Treatment Product Portfolio
Table 81. BioFarma Recent Development
Table 82. GreenSignal Bio Pharma Company Information
Table 83. GreenSignal Bio Pharma Business Overview
Table 84. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2019-2024)
Table 85. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Portfolio
Table 86. GreenSignal Bio Pharma Recent Development
Table 87. China National Biotec Company Information
Table 88. China National Biotec Business Overview
Table 89. China National Biotec Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2019-2024)
Table 90. China National Biotec Tuberculosis Vaccine Treatment Product Portfolio
Table 91. China National Biotec Recent Development
Table 92. Biomed Lublin Company Information
Table 93. Biomed Lublin Business Overview
Table 94. Biomed Lublin Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2019-2024)
Table 95. Biomed Lublin Tuberculosis Vaccine Treatment Product Portfolio
Table 96. Biomed Lublin Recent Development
Table 97. Taj Pharmaceuticals Company Information
Table 98. Taj Pharmaceuticals Business Overview
Table 99. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2019-2024)
Table 100. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Portfolio
Table 101. Taj Pharmaceuticals Recent Development
Table 102. Ataulpho de Paiva Company Information
Table 103. Ataulpho de Paiva Business Overview
Table 104. Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2019-2024)
Table 105. Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Portfolio
Table 106. Ataulpho de Paiva Recent Development
Table 107. IVAC Company Information
Table 108. IVAC Business Overview
Table 109. IVAC Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2019-2024)
Table 110. IVAC Tuberculosis Vaccine Treatment Product Portfolio
Table 111. IVAC Recent Development
Table 112. Queen Saovabha Mem. Inst Company Information
Table 113. Queen Saovabha Mem. Inst Business Overview
Table 114. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2019-2024)
Table 115. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Portfolio
Table 116. Queen Saovabha Mem. Inst Recent Development
Table 117. Microgen Company Information
Table 118. Microgen Business Overview
Table 119. Microgen Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2019-2024)
Table 120. Microgen Tuberculosis Vaccine Treatment Product Portfolio
Table 121. Microgen Recent Development
Table 122. North America Tuberculosis Vaccine Treatment Revenue by Type (2019-2024) & (US$ Million)
Table 123. North America Tuberculosis Vaccine Treatment Revenue by Type (2025-2030) & (US$ Million)
Table 124. North America Tuberculosis Vaccine Treatment Sales by Type (2019-2024) & (K Dose)
Table 125. North America Tuberculosis Vaccine Treatment Sales by Type (2025-2030) & (K Dose)
Table 126. North America Tuberculosis Vaccine Treatment Sales Price by Type (2019-2024) & (USD/K Dose)
Table 127. North America Tuberculosis Vaccine Treatment Sales Price by Type (2025-2030) & (USD/K Dose)
Table 128. North America Tuberculosis Vaccine Treatment Revenue by Application (2019-2024) & (US$ Million)
Table 129. North America Tuberculosis Vaccine Treatment Revenue by Application (2025-2030) & (US$ Million)
Table 130. North America Tuberculosis Vaccine Treatment Sales by Application (2019-2024) & (K Dose)
Table 131. North America Tuberculosis Vaccine Treatment Sales by Application (2025-2030) & (K Dose)
Table 132. North America Tuberculosis Vaccine Treatment Sales Price by Application (2019-2024) & (USD/K Dose)
Table 133. North America Tuberculosis Vaccine Treatment Sales Price by Application (2025-2030) & (USD/K Dose)
Table 134. North America Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 135. North America Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 136. North America Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 137. North America Tuberculosis Vaccine Treatment Sales by Country (2019 VS 2023 VS 2030) & (K Dose)
Table 138. North America Tuberculosis Vaccine Treatment Sales by Country (2019-2024) & (K Dose)
Table 139. North America Tuberculosis Vaccine Treatment Sales by Country (2025-2030) & (K Dose)
Table 140. North America Tuberculosis Vaccine Treatment Sales Price by Country (2019-2024) & (USD/K Dose)
Table 141. North America Tuberculosis Vaccine Treatment Sales Price by Country (2025-2030) & (USD/K Dose)
Table 142. US Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 143. Canada Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 144. Europe Tuberculosis Vaccine Treatment Revenue by Type (2019-2024) & (US$ Million)
Table 145. Europe Tuberculosis Vaccine Treatment Revenue by Type (2025-2030) & (US$ Million)
Table 146. Europe Tuberculosis Vaccine Treatment Sales by Type (2019-2024) & (K Dose)
Table 147. Europe Tuberculosis Vaccine Treatment Sales by Type (2025-2030) & (K Dose)
Table 148. Europe Tuberculosis Vaccine Treatment Sales Price by Type (2019-2024) & (USD/K Dose)
Table 149. Europe Tuberculosis Vaccine Treatment Sales Price by Type (2025-2030) & (USD/K Dose)
Table 150. Europe Tuberculosis Vaccine Treatment Revenue by Application (2019-2024) & (US$ Million)
Table 151. Europe Tuberculosis Vaccine Treatment Revenue by Application (2025-2030) & (US$ Million)
Table 152. Europe Tuberculosis Vaccine Treatment Sales by Application (2019-2024) & (K Dose)
Table 153. Europe Tuberculosis Vaccine Treatment Sales by Application (2025-2030) & (K Dose)
Table 154. Europe Tuberculosis Vaccine Treatment Sales Price by Application (2019-2024) & (USD/K Dose)
Table 155. Europe Tuberculosis Vaccine Treatment Sales Price by Application (2025-2030) & (USD/K Dose)
Table 156. Europe Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 157. Europe Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 158. Europe Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 159. Europe Tuberculosis Vaccine Treatment Sales by Country (2019 VS 2023 VS 2030) & (K Dose)
Table 160. Europe Tuberculosis Vaccine Treatment Sales by Country (2019-2024) & (K Dose)
Table 161. Europe Tuberculosis Vaccine Treatment Sales by Country (2025-2030) & (K Dose)
Table 162. Europe Tuberculosis Vaccine Treatment Sales Price by Country (2019-2024) & (USD/K Dose)
Table 163. Europe Tuberculosis Vaccine Treatment Sales Price by Country (2025-2030) & (USD/K Dose)
Table 164. Germany Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 165. France Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 166. Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 167. Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 168. Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 169. China Tuberculosis Vaccine Treatment Revenue by Type (2019-2024) & (US$ Million)
Table 170. China Tuberculosis Vaccine Treatment Revenue by Type (2025-2030) & (US$ Million)
Table 171. China Tuberculosis Vaccine Treatment Sales by Type (2019-2024) & (K Dose)
Table 172. China Tuberculosis Vaccine Treatment Sales by Type (2025-2030) & (K Dose)
Table 173. China Tuberculosis Vaccine Treatment Sales Price by Type (2019-2024) & (USD/K Dose)
Table 174. China Tuberculosis Vaccine Treatment Sales Price by Type (2025-2030) & (USD/K Dose)
Table 175. China Tuberculosis Vaccine Treatment Revenue by Application (2019-2024) & (US$ Million)
Table 176. China Tuberculosis Vaccine Treatment Revenue by Application (2025-2030) & (US$ Million)
Table 177. China Tuberculosis Vaccine Treatment Sales by Application (2019-2024) & (K Dose)
Table 178. China Tuberculosis Vaccine Treatment Sales by Application (2025-2030) & (K Dose)
Table 179. China Tuberculosis Vaccine Treatment Sales Price by Application (2019-2024) & (USD/K Dose)
Table 180. China Tuberculosis Vaccine Treatment Sales Price by Application (2025-2030) & (USD/K Dose)
Table 181. Asia Tuberculosis Vaccine Treatment Revenue by Type (2019-2024) & (US$ Million)
Table 182. Asia Tuberculosis Vaccine Treatment Revenue by Type (2025-2030) & (US$ Million)
Table 183. Asia Tuberculosis Vaccine Treatment Sales by Type (2019-2024) & (K Dose)
Table 184. Asia Tuberculosis Vaccine Treatment Sales by Type (2025-2030) & (K Dose)
Table 185. Asia Tuberculosis Vaccine Treatment Sales Price by Type (2019-2024) & (USD/K Dose)
Table 186. Asia Tuberculosis Vaccine Treatment Sales Price by Type (2025-2030) & (USD/K Dose)
Table 187. Asia Tuberculosis Vaccine Treatment Revenue by Application (2019-2024) & (US$ Million)
Table 188. Asia Tuberculosis Vaccine Treatment Revenue by Application (2025-2030) & (US$ Million)
Table 189. Asia Tuberculosis Vaccine Treatment Sales by Application (2019-2024) & (K Dose)
Table 190. Asia Tuberculosis Vaccine Treatment Sales by Application (2025-2030) & (K Dose)
Table 191. Asia Tuberculosis Vaccine Treatment Sales Price by Application (2019-2024) & (USD/K Dose)
Table 192. Asia Tuberculosis Vaccine Treatment Sales Price by Application (2025-2030) & (USD/K Dose)
Table 193. Asia Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 194. Asia Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 195. Asia Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 196. Asia Tuberculosis Vaccine Treatment Sales by Country (2019 VS 2023 VS 2030) & (K Dose)
Table 197. Asia Tuberculosis Vaccine Treatment Sales by Country (2019-2024) & (K Dose)
Table 198. Asia Tuberculosis Vaccine Treatment Sales by Country (2025-2030) & (K Dose)
Table 199. Asia Tuberculosis Vaccine Treatment Sales Price by Country (2019-2024) & (USD/K Dose)
Table 200. Asia Tuberculosis Vaccine Treatment Sales Price by Country (2025-2030) & (USD/K Dose)
Table 201. Japan Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 202. South Korea Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 203. Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 204. Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 205. Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 206. Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 207. Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 208. Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 209. MEALA Tuberculosis Vaccine Treatment Revenue by Type (2019-2024) & (US$ Million)
Table 210. MEALA Tuberculosis Vaccine Treatment Revenue by Type (2025-2030) & (US$ Million)
Table 211. MEALA Tuberculosis Vaccine Treatment Sales by Type (2019-2024) & (K Dose)
Table 212. MEALA Tuberculosis Vaccine Treatment Sales by Type (2025-2030) & (K Dose)
Table 213. MEALA Tuberculosis Vaccine Treatment Sales Price by Type (2019-2024) & (USD/K Dose)
Table 214. MEALA Tuberculosis Vaccine Treatment Sales Price by Type (2025-2030) & (USD/K Dose)
Table 215. MEALA Tuberculosis Vaccine Treatment Revenue by Application (2019-2024) & (US$ Million)
Table 216. MEALA Tuberculosis Vaccine Treatment Revenue by Application (2025-2030) & (US$ Million)
Table 217. MEALA Tuberculosis Vaccine Treatment Sales by Application (2019-2024) & (K Dose)
Table 218. MEALA Tuberculosis Vaccine Treatment Sales by Application (2025-2030) & (K Dose)
Table 219. MEALA Tuberculosis Vaccine Treatment Sales Price by Application (2019-2024) & (USD/K Dose)
Table 220. MEALA Tuberculosis Vaccine Treatment Sales Price by Application (2025-2030) & (USD/K Dose)
Table 221. MEALA Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 222. MEALA Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 223. MEALA Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 224. MEALA Tuberculosis Vaccine Treatment Sales by Country (2019 VS 2023 VS 2030) & (K Dose)
Table 225. MEALA Tuberculosis Vaccine Treatment Sales by Country (2019-2024) & (K Dose)
Table 226. MEALA Tuberculosis Vaccine Treatment Sales by Country (2025-2030) & (K Dose)
Table 227. MEALA Tuberculosis Vaccine Treatment Sales Price by Country (2019-2024) & (USD/K Dose)
Table 228. MEALA Tuberculosis Vaccine Treatment Sales Price by Country (2025-2030) & (USD/K Dose)
Table 229. Mexico Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 230. Brazil Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 231. Israel Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 232. Argentina Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 233. Colombia Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 234. Turkey Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 235. Saudi Arabia Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 236. UAE Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Table 237. Key Raw Materials
Table 238. Raw Materials Key Suppliers
Table 239. Tuberculosis Vaccine Treatment Distributors List
Table 240. Tuberculosis Vaccine Treatment Customers List
Table 241. Research Programs/Design for This Report
Table 242. Authors List of This Report
Table 243. Secondary Sources
Table 244. Primary Sources
List of Figures
Figure 1. Tuberculosis Vaccine Treatment Product Picture
Figure 2. Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Tuberculosis Vaccine Treatment Market Size Share 2019 VS 2023 VS 2030
Figure 4. Immune Vaccine Picture
Figure 5. Therapy Vaccine Picture
Figure 6. Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Tuberculosis Vaccine Treatment Market Size Share 2019 VS 2023 VS 2030
Figure 8. Self-Procurement Picture
Figure 9. UNICEF Picture
Figure 10. Other Picture
Figure 11. Global Tuberculosis Vaccine Treatment Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Tuberculosis Vaccine Treatment Revenue (2019-2030) & (US$ Million)
Figure 13. Global Tuberculosis Vaccine Treatment Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 14. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region: 2023 Versus 2030
Figure 15. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2019-2030)
Figure 16. Global Tuberculosis Vaccine Treatment Sales (2019-2030) & (K Dose)
Figure 17. Global Tuberculosis Vaccine Treatment Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Dose)
Figure 18. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Tuberculosis Vaccine Treatment Sales YoY (2019-2030) & (K Dose)
Figure 20. Europe Tuberculosis Vaccine Treatment Sales YoY (2019-2030) & (K Dose)
Figure 21. China Tuberculosis Vaccine Treatment Sales YoY (2019-2030) & (K Dose)
Figure 22. Asia (Excluding China) Tuberculosis Vaccine Treatment Sales YoY (2019-2030) & (K Dose)
Figure 23. Middle East, Africa and Latin America (Excluding China) Tuberculosis Vaccine Treatment Sales YoY (2019-2030) & (K Dose)
Figure 24. Global Tuberculosis Vaccine Treatment Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 25. Global Tuberculosis Vaccine Treatment Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 27. Global Tuberculosis Vaccine Treatment Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 28. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 29. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2019-2030)
Figure 30. Global Tuberculosis Vaccine Treatment Sales by Type (2019 VS 2023 VS 2030) & (K Dose)
Figure 31. Global Tuberculosis Vaccine Treatment Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 32. Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2019-2030)
Figure 33. Global Tuberculosis Vaccine Treatment Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 34. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 35. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2019-2030)
Figure 36. Global Tuberculosis Vaccine Treatment Sales by Application (2019 VS 2023 VS 2030) & (K Dose)
Figure 37. Global Tuberculosis Vaccine Treatment Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 38. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2019-2030)
Figure 39. North America Tuberculosis Vaccine Treatment Revenue Share by Type (2019-2030)
Figure 40. North America Tuberculosis Vaccine Treatment Sales Share by Type (2019-2030)
Figure 41. North America Tuberculosis Vaccine Treatment Revenue Share by Application (2019-2030)
Figure 42. North America Tuberculosis Vaccine Treatment Sales Share by Application (2019-2030)
Figure 43. North America Tuberculosis Vaccine Treatment Revenue Share by Country (2019-2030)
Figure 44. North America Tuberculosis Vaccine Treatment Sales Share by Country (2019-2030)
Figure 45. Europe Tuberculosis Vaccine Treatment Revenue Share by Type (2019-2030)
Figure 46. Europe Tuberculosis Vaccine Treatment Sales Share by Type (2019-2030)
Figure 47. Europe Tuberculosis Vaccine Treatment Revenue Share by Application (2019-2030)
Figure 48. Europe Tuberculosis Vaccine Treatment Sales Share by Application (2019-2030)
Figure 49. Europe Tuberculosis Vaccine Treatment Revenue Share by Country (2019-2030)
Figure 50. Europe Tuberculosis Vaccine Treatment Sales Share by Country (2019-2030)
Figure 51. China Tuberculosis Vaccine Treatment Revenue Share by Type (2019-2030)
Figure 52. China Tuberculosis Vaccine Treatment Sales Share by Type (2019-2030)
Figure 53. China Tuberculosis Vaccine Treatment Revenue Share by Application (2019-2030)
Figure 54. China Tuberculosis Vaccine Treatment Sales Share by Application (2019-2030)
Figure 55. Asia Tuberculosis Vaccine Treatment Revenue Share by Type (2019-2030)
Figure 56. Asia Tuberculosis Vaccine Treatment Sales Share by Type (2019-2030)
Figure 57. Asia Tuberculosis Vaccine Treatment Revenue Share by Application (2019-2030)
Figure 58. Asia Tuberculosis Vaccine Treatment Sales Share by Application (2019-2030)
Figure 59. Asia Tuberculosis Vaccine Treatment Revenue Share by Country (2019-2030)
Figure 60. Asia Tuberculosis Vaccine Treatment Sales Share by Country (2019-2030)
Figure 61. MEALA Tuberculosis Vaccine Treatment Revenue Share by Type (2019-2030)
Figure 62. MEALA Tuberculosis Vaccine Treatment Sales Share by Type (2019-2030)
Figure 63. MEALA Tuberculosis Vaccine Treatment Revenue Share by Application (2019-2030)
Figure 64. MEALA Tuberculosis Vaccine Treatment Sales Share by Application (2019-2030)
Figure 65. MEALA Tuberculosis Vaccine Treatment Revenue Share by Country (2019-2030)
Figure 66. MEALA Tuberculosis Vaccine Treatment Sales Share by Country (2019-2030)
Figure 67. Tuberculosis Vaccine Treatment Value Chain
Figure 68. Manufacturing Cost Structure
Figure 69. Tuberculosis Vaccine Treatment Production Mode & Process
Figure 70. Direct Comparison with Distribution Share
Figure 71. Distributors Profiles
Figure 72. Years Considered
Figure 73. Research Process
Figure 74. Key Executives Interviewed
